2.1
Zanubrutinib (Brukinsa, BeiGene) is indicated for 'the treatment of adult patients with chronic lymphocytic leukaemia'.
2 Information about zanubrutinib
Dosage in the marketing authorisation
2.2
The dosage schedule is available in the summary of product characteristics for zanubrutinib.
Price
2.3
A 120‑pack of 80‑mg zanubrutinib capsules costs £4,928.65 (excluding VAT; BNF online accessed September 2023). The company has a commercial arrangement. This makes zanubrutinib available to the NHS with a discount. The size of the discount is commercial in confidence. It is the company's responsibility to let relevant NHS organisations know details of the discount.